| Literature DB >> 20731854 |
Linda Douw1, Edwin van Dellen, Marjolein de Groot, Jan J Heimans, Martin Klein, Cornelis J Stam, Jaap C Reijneveld.
Abstract
BACKGROUND: Both epilepsy patients and brain tumor patients show altered functional connectivity and less optimal brain network topology when compared to healthy controls, particularly in the theta band. Furthermore, the duration and characteristics of epilepsy may also influence functional interactions in brain networks. However, the specific features of connectivity and networks in tumor-related epilepsy have not been investigated yet. We hypothesize that epilepsy characteristics are related to (theta band) connectivity and network architecture in operated glioma patients suffering from epileptic seizures. Included patients participated in a clinical study investigating the effect of levetiracetam monotherapy on seizure frequency in glioma patients, and were assessed at two time points: directly after neurosurgery (t1), and six months later (t2). At these time points, magnetoencephalography (MEG) was recorded and information regarding clinical status and epilepsy history was collected. Functional connectivity was calculated in six frequency bands, as were a number of network measures such as normalized clustering coefficient and path length.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20731854 PMCID: PMC2936439 DOI: 10.1186/1471-2202-11-103
Source DB: PubMed Journal: BMC Neurosci ISSN: 1471-2202 Impact factor: 3.288
Patient characteristics at t1
| Age | Gender | Seizure type | Time since 1st seizure (months) | Seizure frequency (per month) | Total number of seizures | Type of surgery | Histopathological diagnosis | Tumor localization | CT | RT | DEX | KPS | Barthel | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 57 | M | PS | 65 | 4-30 | 10 | R | OIII | RF | N | Y | N | 90 | 20 |
| 2 | 43 | M | GS | 19 | > 30 | 120 | R | AII | RF | Y | N | N | 70 | 19 |
| 3 | 46 | F | GS | 163 | 0 | 11 | R | OII | LF | Y | N | N | 90 | 20 |
| 4 | 49 | M | GS | 30 | > 30 | 20 | R | GBM | LF | Y | Y | N | 80 | 20 |
| 5 | 68 | M | PS | 61 | > 30 | 2 | R | GBM | RT | Y | N | Y | 100 | 20 |
| 6 | 36 | M | GS | 5 | 0 | 1 | R | AIII | RF | N | Y | N | 90 | 20 |
| 7 | 30 | M | GS | 21 | 1 | 2 | R | AII | RF | N | N | N | 100 | 20 |
| 8 | 50 | M | GS | 11 | 1 | 1 | B | AIII | LPO | Y | Y | Y | 90 | 20 |
| 9 | 25 | F | GS | 15 | 4-30 | 8 | B | GBM | RT | Y | Y | Y | 90 | 20 |
| 10 | 61 | M | GS | 32 | 0 | 1 | R | GBM | RF | Y | Y | Y | 100 | 20 |
| 11 | 45 | M | GS | 117 | 1 | 1 | R | OIII | RT | N | Y | N | 90 | 20 |
| 12 | 37 | F | GS | 33 | 1 | 2 | R | GBM | RFT | Y | Y | N | 90 | 20 |
| 13 | 47 | M | GS | 38 | 1 | 3 | R | AIII | LF | N | Y | N | 70 | 19 |
| 14 | 29 | M | GS | 22 | 1-4 | 3 | R | GBM | RF | Y | Y | N | 90 | 20 |
| 15 | 49 | F | PS | 9 | 1 | 2 | R | GBM | LF | Y | Y | Y | 80 | 16 |
| 16 | 48 | M | GS | 10 | 0 | 1 | R | GBM | RT | Y | Y | N | 100 | 20 |
| 17 | 25 | M | GS | 16 | 1 | 3 | R | GBM | RT | Y | Y | N | 100 | 20 |
Note. CT = chemotherapy, RT = radiotherapy, DEX = dexamethasone, KPS = Karnofsky performance status, M = male, F = female, PS = partial seizures, GS = generalized seizures, R = (sub)total resection, B = stereotactic biopsy, OII or III = oligodendroglioma WHO grade II or III, AII or III = astrocytoma WHO grade II or III, GBM = glioblastoma multiforme, RF = right frontal, LF = left frontal, RT = right temporal, LPO = left parieto-occipital, RFT = right fronto-temporal, N = no, Y = yes.
Patient characteristics at t2
| Seizure frequency (per month) | Total number of seizures | CT | RT | DEX | KPS | Barthel | |
|---|---|---|---|---|---|---|---|
| 1 | 0 | 10 | N | N | N | 100 | 19 |
| 3 | 0 | 11 | N | N | N | 90 | 20 |
| 4 | 1 | 22 | Y | N | Y | 80 | 20 |
| 6 | 0 | 1 | N | N | N | 90 | 20 |
| 7 | 0 | 2 | N | N | N | 100 | 20 |
| 8 | 1 | 3 | Y | N | Y | 100 | 20 |
| 9 | 0 | 8 | N | N | Y | 90 | 20 |
| 10 | 0 | 1 | Y | N | N | 90 | 20 |
| 11 | 0 | 1 | N | N | N | 90 | 20 |
| 12 | 0 | 2 | Y | N | N | 80 | 20 |
| 15 | 0 | 2 | N | N | N | 80 | 18 |
| 16 | 0 | 1 | Y | N | N | 90 | 20 |
Note. CT = chemotherapy, RT = radiotherapy, DEX = dexamethasone, KPS = Karnofsky performance status, N = no, Y = yes.
Figure 1Scatterplots of correlations between functional connectivity, network characteristics, and total number of seizures at both t1 and t2. Note. Left column: scatterplots excluding outlying patients (patient 2 in table 1), right column: scatterplots including this patient. (A) correlation between theta band phase lag index (PLI) at t1 without outlying patient, (B) correlation between theta band PLI at t1 with outlying patient, (C) correlation between theta band path length and total number of seizures at t1 without outlying patient, (D) correlation between theta band path length and total number of seizures at t1 with outlying patient, (E) correlation between theta band edge weight correlation and total number of seizures at t1 without outlying patient, (F) correlation between theta band edge weight correlation and total number of seizures at t1 with outlying patient, and (G) correlation between theta band PLI and total number of seizures at t2.
Figure 2Mean PLI at both time points. Note. PLI = phase lag index.
Figure 3Mean network characteristics at both time points. Note. Cw/Cws = weighted normalized clustering coefficient, Lw/Lws = weighted normalized clustering
coefficient, S = small-world index, Wr = edge weight correlation.